/wp-content/uploads/logo.png
0
0
Emily Hennes
/wp-content/uploads/logo.png
Emily Hennes2023-10-24 13:15:092023-11-01 12:26:23Endeavor BioMedicines Appoints Paul Frohna, M.D., Ph.D., as Chief Medical Officer
/wp-content/uploads/logo.png
0
0
Emily Hennes
/wp-content/uploads/logo.png
Emily Hennes2023-10-17 10:10:442023-10-18 12:35:53Endeavor BioMedicines Enters License Agreement with Hummingbird Bioscience for Worldwide Rights to HMBD-501, a Next Generation HER3-Targeted Antibody-Drug Conjugate (ADC)
/wp-content/uploads/logo.png
0
0
eallison
/wp-content/uploads/logo.png
eallison2023-09-01 14:27:362023-09-01 14:40:58Endeavor BioMedicines Completes Enrollment in Phase 2a Clinical Trial of ENV-101 (Taladegib) for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)
https://endeavorbiomedicines.com/wp-content/uploads/techcrunch-logo-1.svg
52
364
Emily Hennes
/wp-content/uploads/logo.png
Emily Hennes2022-01-19 15:49:162022-01-19 15:49:16Endeavor BioMedicines raises $62 million to combat pulmonary disease
https://endeavorbiomedicines.com/wp-content/uploads/PF_News_logo-gray-01.svg
100
100
Emily Hennes
/wp-content/uploads/logo.png
Emily Hennes2022-01-19 15:47:182022-02-01 18:52:241st Patient Dosed in Trial of IPF Therapy Candidate Taladegib
https://endeavorbiomedicines.com/wp-content/uploads/scrip-logo-1.svg
52
169
Emily Hennes
/wp-content/uploads/logo.png
Emily Hennes2022-01-19 15:50:002022-01-19 15:50:00Endeavor Launches With $62m And A Hedgehog Inhibitor From Lilly
https://endeavorbiomedicines.com/wp-content/uploads/Stat_News_logo-gray.svg
100
100
Emily Hennes
/wp-content/uploads/logo.png
Emily Hennes2022-01-21 17:34:072022-01-21 17:47:16Serial biotech entrepreneur John Hood raises $62 million for company aimed at deadly lung disease
https://endeavorbiomedicines.com/wp-content/uploads/linkedin-gray.svg
100
100
Emily Hennes
/wp-content/uploads/logo.png
Emily Hennes2022-01-31 18:09:392022-02-01 18:52:55My newest puzzle, Endeavor BioMedicines, and the chance to reverse a devastating pulmonary disease
/wp-content/uploads/logo.png
0
0
David Anderson
/wp-content/uploads/logo.png
David Anderson2022-02-07 05:05:122022-02-10 08:50:07Endeavor BioMedicines Closes $101M Series B Financing to Advance Clinical-Stage Precision Medicine Pipeline
/wp-content/uploads/logo.png
0
0
Emily Hennes
/wp-content/uploads/logo.png
Emily Hennes2022-01-19 14:48:512022-02-03 18:59:03Endeavor Biomedicines doses first patient in phase 2 clinical trial of Taladegib (ENV-101) for idiopathic pulmonary fibrosis; appoints chief medical officer
Scroll to top
